These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37422199)

  • 1. Close link between antiphosphatidylserine/prothrombin antibodies, lupus anticoagulant, and activated protein C resistance in tetra antiphospholipid antibody-positive subjects.
    Pontara E; Bison E; Cattini MG; Tonello M; Denas G; Pengo V
    J Thromb Haemost; 2023 Nov; 21(11):3138-3144. PubMed ID: 37422199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
    Vandevelde A; Chayoua W; de Laat B; Moore GW; Musiał J; Zuily S; Wahl D; Devreese KMJ
    J Thromb Haemost; 2022 Sep; 20(9):2136-2150. PubMed ID: 35713971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of obstetric antiphospholipid syndrome: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
    Vandevelde A; Gris JC; Moore GW; Musiał J; Zuily S; Wahl D; Devreese KMJ
    J Thromb Haemost; 2023 Jul; 21(7):1981-1994. PubMed ID: 37061133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome.
    Shi H; Zheng H; Yin YF; Hu QY; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Zhou JF; Norman GL; Gong HY; Shi XM; Peng YB; Wang XF; Yang CD
    Clin Chem Lab Med; 2018 Mar; 56(4):614-624. PubMed ID: 29166262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-phosphatidylserine/prothrombin complex antibodies (aPS/PT) increase the risk for thrombosis based on lupus anticoagulant positivity.
    Zhang Y; Su Y; Guo H; Wang L; Li A; Wang C; Zhang J; Qiao R
    Clin Biochem; 2023 Feb; 112():17-23. PubMed ID: 36535385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers.
    Tonello M; Mattia E; Favaro M; Del Ross T; Calligaro A; Salvan E; Hoxha A; Fedrigo M; Ruffatti A
    Thromb Res; 2019 May; 177():157-160. PubMed ID: 30903876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid syndrome: Reversal of antiphosphatidylserine/prothrombin-induced activated protein C resistance.
    Pontara E; Cattini MG; Bison E; Cheng C; Denas G; Pengo V
    Thromb Res; 2022 Oct; 218():17-23. PubMed ID: 35973396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.
    Heikal NM; Jaskowski TD; Malmberg E; Lakos G; Branch DW; Tebo AE
    Clin Exp Immunol; 2015 May; 180(2):218-26. PubMed ID: 25522978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
    Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T
    Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphosphatidylserine/prothrombin complex antibodies as a determinant of prothrombotic plasma fibrin clot properties in patients with antiphospholipid syndrome.
    Ząbczyk M; Celińska-Löwenhoff M; Plens K; Iwaniec T; Musiał J; Undas A
    J Thromb Haemost; 2019 Oct; 17(10):1746-1755. PubMed ID: 31220407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
    Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
    Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients.
    Zhu L; Li C; Liu N; Yang X; Jia RL; Mu R; Su Y; Li ZG
    Clin Rheumatol; 2017 Feb; 36(2):401-406. PubMed ID: 28050648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE.
    Elbagir S; Grosso G; Mohammed NA; Elshafie AI; Elagib EM; Zickert A; Manivel VA; Pertsinidou E; Nur MAM; Gunnarsson I; Rönnelid J; Svenungsson E
    Lupus; 2021 Jul; 30(8):1289-1299. PubMed ID: 33957795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lupus anticoagulant titer is associated with elevated antiphosphatidylserine/prothrombin immunoglobulin-M isotype antibody levels.
    Saadalla A; Chen D; Stuart M; Pruthi R; Heikal N; Snyder M; Ashrani A; Seheult J
    Int J Lab Hematol; 2024 Aug; 46(4):695-704. PubMed ID: 38380742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential markers of antiphospholipid syndrome.
    Vlagea A; Gil A; Cuesta MV; Arribas F; Diez J; Lavilla P; Pascual-Salcedo D
    Clin Appl Thromb Hemost; 2013 Jun; 19(3):289-96. PubMed ID: 22387581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-phosphatidyl-serine/prothrombin antibodies (aPS/PT) in isolated lupus anticoagulant (LA): is their presence linked to dual test positivity?
    Tonello M; Bison E; Cattini MG; Pontara E; Iaccarino L; Denas G; Cheng C; Pengo V
    Clin Chem Lab Med; 2021 Nov; 59(12):1950-1953. PubMed ID: 34390635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) and risk of obstetric anti-phospholipid syndrome.
    Zhang X; Liu Z; Guo F; Wang Q; Bai W; Zhao A
    Am J Reprod Immunol; 2023 Jun; 89(6):e13621. PubMed ID: 36181461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-phosphatidyl-serine/prothrombin (aPS/PT) antibodies are superior predictors of LAC presence and APS diagnoses: A single center study.
    Saadalla A; Nandakumar V
    Clin Chim Acta; 2024 Feb; 554():117761. PubMed ID: 38195020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extra-criteria antiphospholipid antibodies in patients with small vessel brain lesions and clinical manifestations associated with antiphospholipid syndrome.
    Estévez MÁ; Lanio N; Molina Á; Jiménez-León MR; Picado MJ; Esteban E; Sánchez S; Pallarés L; Julià MR
    J Stroke Cerebrovasc Dis; 2023 May; 32(5):107034. PubMed ID: 36842350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.